SGLT2 inhibitors lower blood sugar by dumping glucose into your urine
A direct unit-to-unit comparison is meaningless without accounting for concentration, potency, and receptor activity differences
Administered as a once-weekly subcutaneous injection, tirzepatide is available in doses ranging from 2.5 mg to 15 mg, with recommended dose escalation in 2.5 mg increments approximately every 4 weeks to minimize gastrointestinal side effects
Whether you're in Fairfield, Ohio, or elsewhere, for those covered by Medicare, Medicaid, or other commercial insurance plans, we confirm coverage before your first consultation, ensuring clarity and eliminating financial surprises
Clinical data from the SURMOUNT-1 trial published in the New England Journal of Medicine demonstrated dose-dependent weight loss: 16% average body weight reduction at 5mg, 21.4% at 10mg, and 22.5% at 15mg over 72 weeks